The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
Pre-existing cross-reactive immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins in infection-naive subjects have been described by several studies. In particular, regions of high homology between SARS-CoV-2 and common cold coronaviruses have been highlighted as...
المؤلفون الرئيسيون: | Murray, SM, Ansari, AM, Frater, J, Klenerman, P, Dunachie, S, Barnes, E, Ogbe, A |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Springer Nature
2022
|
مواد مشابهة
-
SARS-CoV-2 antibody responses post-vaccination in UK healthcare workers with pre-existing medical conditions: a cohort study
حسب: Ward, V, وآخرون
منشور في: (2022) -
SARS-CoV-2 antibody responses post-vaccination in UK healthcare workers with pre-existing medical conditions: a cohort study
حسب: Eleanor Barnes, وآخرون
منشور في: (2022-12-01) -
Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination
حسب: Caiqin Hu, وآخرون
منشور في: (2022-09-01) -
IgM responses following SARS-CoV-2 vaccination: insights into protective and pre-existing immunity
حسب: Judith Fraussen
منشور في: (2022-03-01) -
Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family members
حسب: Cecilia Jay, وآخرون
منشور في: (2023-08-01)